Source: Visionstate.
  • Visionstate (VIS) has announced a private placement for gross proceeds of up to $500,000
  • The company will issue up to 12,500,000 common shares priced at $0.04 per share
  • Visionstate invests in the research and development of promising new technology in the realm of the Internet of Things
  • Visionstate Corp. (VIS) is unchanged on the day, trading at C$0.03 per share at 2:45 pm ET

Visionstate (VIS) has announced a private placement for gross proceeds of up to $500,000.

The company will issue up to 12,500,000 common shares priced at $0.04 per share.

Each share purchased under the offering will include one warrant that will entitle the holder to acquire an additional common share at $0.05 for up to 24 months.

The net proceeds will be used for marketing and sales initiatives, funding research and development, operating capital and investigating a US quotation on the OTCQB.

Visionstate invests in the research and development of promising new technology in the realm of the Internet of Things, big data and analytics, and sustainability.

The footprint of its WANDA™ smart device now extends to hospitals, airports, shopping centers, and other public facilities across North America.

Visionstate Corp. (VIS) is unchanged on the day, trading at C$0.03 per share at 2:45 pm ET.

More From The Market Online

Small-cap Canadian healthcare firm expands AI-screening at home and abroad

Diagnos (TSXV:ADK) uses AI through its CARA platform to help detect eye diseases like diabetic retinopathy & age-related macular degeneration

The 5-Minute Investor Podcast, Ep. 85: Standout AI healthcare stocks

Listen to episode 85 of The 5-Minute Investor Podcast, featuring analysis on AI healthcare stocks Diagnos and CeriBell.

This healthtech company improves neurological care with AI

CeriBell is a healthtech company applying AI to neurological critical care, vastly improving diagnoses versus legacy technology.